ColgatePalmolive (CL)
(Delayed Data from NYSE)
$100.46 USD
-0.07 (-0.07%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $100.50 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$100.46 USD
-0.07 (-0.07%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $100.50 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Zacks News
Philip Morris' Q3 Earnings Coming Up: Here's What You Should Know
by Zacks Equity Research
Philip Morris' Q3 results are likely to reflect gains from pricing and strength in smoke-free products, especially IQOS and ZYN.
Colgate-Palmolive (CL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kimberly-Clark's Q3 Earnings Coming Up: Here's What You Should Know
by Zacks Equity Research
KMB's Q3 earnings are likely to reflect the adverse impact of shifting consumer behaviors, retail inventory destocking and rising manufacturing costs.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
The Zacks Analyst Blog Highlights Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive
by Zacks Equity Research
Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive are part of the Zacks top Analyst Blog.
The Zacks Analyst Blog Highlights Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive
by Zacks Equity Research
Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive are part of the Zacks top Analyst Blog.
Pre-Q1 Earnings: To Buy or Not to Buy Procter & Gamble Stock?
by Rajani Lohia
Gains from strong pricing, cost-saving and productivity measures should aid PG in Q1 amid Greater China issues, geopolitical tensions and currency volatility.
Helen of Troy Q2 Earnings Coming Up: Here's What You Should Know
by Zacks Equity Research
HELE's Q2 performance is likely to reflect the impacts of weak consumer spending amid inflationary pressures.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Colgate-Palmolive (CL) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Top Analyst Reports for NextEra Energy, Lockheed Martin & Palo Alto Networks
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NextEra Energy, Inc. (NEE), Lockheed Martin Corporation (LMT) and Palo Alto Networks, Inc. (PANW), as well as two micro-cap stocks Rave Restaurant Group, Inc. (RAVE) and AXIL Brands, Inc. (AXIL).
Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Lamb Weston (LW) Matches Q1 Earnings Estimates
by Zacks Equity Research
Lamb Weston (LW) delivered earnings and revenue surprises of 0% and 6.36%, respectively, for the quarter ended August 2024. Do the numbers hold clues to what lies ahead for the stock?
STZ Q2 Earnings: Will Soft Wine & Spirits Trends to Mar Results?
by Zacks Equity Research
Soft demand trends and category headwinds in the wine & spirits business are expected to affect Constellation Brands in Q2, offset by a resilient beer segment.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Zacks Industry Outlook Highlights Unilever, The Procter & Gamble, Colgate-Palmolive, Henkel and Church & Dwight
by Zacks Equity Research
Unilever, The Procter & Gamble, Colgate-Palmolive, Henkel and Church & Dwight are part of the Zacks Industry Outlook article.
Colgate-Palmolive (CL) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Colgate-Palmolive (CL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
5 Soap & Cleaning Materials Stocks to Capitalize on Positive Industry Trends
by Rajani Lohia
Pricing strategies, innovation, digital transformation, and brand building are essential for success in the soap and cleaning materials industry amid rising costs. Companies like UL, PG, CL, HENKY, and CHD are well-positioned to succeed through these initiatives.
Is ColgatePalmolive (CL) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Colgate-Palmolive (CL) and Kimberly-Clark (KMB) have performed compared to their sector so far this year.
Will Growth Strategies Propel Colgate's Stock to New Heights?
by Zacks Equity Research
CL is on a growth track, backed by its innovation strategy, aggressive pricing actions and productivity initiatives.
Procter & Gamble Stock Up 21% YTD: Should You Stay Invested or Exit?
by Rajani Lohia
PG's strong global presence and cost-saving strategies offer promise. However, challenges in key markets and ongoing geopolitical tensions pose risks.
Colgate Stock Trades Near 52-Week High: What's Next for Investors?
by Zacks Equity Research
CL has witnessed consistent growth, with the stock reaching a new 52-week high. Leadership in the oral care market and innovations bolster its performance.
Procter & Gamble (PG) Trades Near 52-Week High: Should You Buy?
by Rajani Lohia
Procter & Gamble (PG) witnesses consistent growth, with the stock creating new 52-week highs in less than two months.
Colgate (CL) Benefits From Innovation & Pricing Actions
by Zacks Equity Research
Colgate's (CL) margins benefit from robust pricing and funding-the-growth and other productivity initiatives.
Inter Parfums (IPAR) Q2 Earnings Top, Sales Up on Robust Demand
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter 2024 results reflect higher sales and earnings on continued momentum in the fragrance market and strength in its legacy and new brands.